Fibric acid derivatives in cardiovascular disease prevention: results from the large clinical trials.
about
Statins but not fibrates improve the atherogenic to anti-atherogenic lipoprotein particle ratio: a randomized crossover study.Opposite regulation of cholesterol levels by the phosphatase and hydrolase domains of soluble epoxide hydrolaseAtherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statinsNovel Role of Soluble Epoxide Hydrolase in Regulating Cholesterol in Mammalian CellsApolipoprotein B genetic variants modify the response to fenofibrate: a GOLDN study.The ACCORD-Lipid study: implications for treatment of dyslipidemia in Type 2 diabetes mellitusRelation of gemfibrozil treatment and high-density lipoprotein subpopulation profile with cardiovascular events in the Veterans Affairs High-Density Lipoprotein Intervention Trial.How can we prevent cardiovascular disease in diabetes.Impact of metabolic syndrome on lipid target achievements in the Arabian Gulf: findings from the CEPHEUS study.Pleiotropic effects and cholesterol-lowering therapy.Combination of fenofibrate plus low-dose nicotinic acid added to statin treatment in type 2 diabetes: An open-label, crossover study
P2860
Q21262011-0B11BB34-538F-4E4B-8033-9D8454F29CABQ24310374-3DC10CB7-E6A5-4353-AA0D-AAC1035EB65CQ28200554-6452FAAF-B32B-4B40-A64D-2626CA8EE7E7Q28384230-F48C7C0E-BBA2-4928-A5FF-B2E576E51195Q34188082-B6AAE30E-1613-41EA-B46D-18213A1EFDB8Q35871965-2CD1B886-EE1D-4B20-8F41-56B959575100Q36372677-8F35CB0A-B006-443F-9E4F-0A90E8A28FC0Q36889170-195029F0-61FE-4E40-81C6-364484A9DC1AQ37129540-E20E5490-CCBC-4931-B9F9-A70628A2C7D7Q37199617-3F0535A6-7F0A-4B97-938A-1DFC85BC1E32Q37663503-A024D9F2-E8CE-4183-9C5D-A674FF455A2E
P2860
Fibric acid derivatives in cardiovascular disease prevention: results from the large clinical trials.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Fibric acid derivatives in car ...... rom the large clinical trials.
@ast
Fibric acid derivatives in car ...... rom the large clinical trials.
@en
type
label
Fibric acid derivatives in car ...... rom the large clinical trials.
@ast
Fibric acid derivatives in car ...... rom the large clinical trials.
@en
prefLabel
Fibric acid derivatives in car ...... rom the large clinical trials.
@ast
Fibric acid derivatives in car ...... rom the large clinical trials.
@en
P1476
Fibric acid derivatives in car ...... from the large clinical trials
@en
P2093
Sander J Robins
P304
P356
10.1097/01.MOL.0000236370.27508.9D
P577
2006-08-01T00:00:00Z